Ligand validation:4IL6

PL9: 2,3-DIMETHYL-5-(3,7,11,15,19,23,27,31,35-NONAMETHYL-2,6,10,14,18,22,26,30,34-HEXATRIACONTANONAENYL-2,5-CYCLOHEXADIENE-1,4-DIONE-2,3-DIMETHYL-5-SOLANESYL-1,4-BENZOQUINONE

PL9 is a Ligand Of Interest in 4IL6 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4IL6_PL9_d_405	85%	46%	0.089	0.955	0.73	1.38	2	10	0	0	100%	1
4IL6_PL9_D_407	83%	45%	0.094	0.952	0.73	1.43	2	13	0	0	100%	1
4IL6_PL9_A_1010	25%	41%	0.193	0.826	0.68	1.63	2	17	0	0	100%	1
4IL6_PL9_a_414	19%	44%	0.206	0.8	0.7	1.49	2	14	0	0	100%	1
5V2C_PL9_d_407	96%	36%	0.069	0.978	1.27	1.32	8	10	0	0	100%	1
5B66_PL9_D_412	93%	36%	0.077	0.97	1.06	1.51	3	12	0	0	100%	1
5ZZN_PL9_D_407	92%	36%	0.081	0.973	1.11	1.47	6	7	0	0	100%	1
8F4C_PL9_D_407	90%	35%	0.083	0.964	0.91	1.71	3	14	0	0	100%	1
7YQ7_PL9_d_408	89%	43%	0.083	0.961	0.77	1.47	2	13	0	0	100%	1
8F4J_PL9_D_406	89%	34%	0.083	0.961	0.92	1.75	2	12	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.